William Williams Email

Head Tech Transfer and Kilo Lab . SEQENS CDMO

Current Roles

Employees:
139
Revenue:
$27.9M
About
Emergence of a new global CDMO Three custom development and manufacturing organizations – PCAS S.A. in France, Chemie Uetikon in Germany and PCI Synthesis in the United States – have joined forces as Seqens CDMO (formerly Novacap) to offer world-class Drug Substance Development and Manufacturing services to the pharmaceutical industry. With three R&D centers, six cGMP / FDA inspected production sites in Europe and the United States supported by two manufacturing sites for the production of critical intermediates and Regulatory Starting Materials (RSMs), the group offers a powerful manufacturing network employing approximately 1200 persons capable to embrace complexity in developing, industrializing and manufacturing complex molecular entities.
SEQENS CDMO Address
SEQENS, 21 Chemin de la Sauvegarde
null, null
United States
SEQENS CDMO Email

Past Companies

SEQENS Pharmaceutical SolutionsHead of Tech Transfer and Kilo Lab
Dow ChemicalSr Chemist
Inotek Pharmaceuticals CorporationPrincipal Scientist

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.